[1] [1] ETTER M C, PANUNTO T W. 1, 3-Bis(m-nitrophenyl)urea: an exceptionally good complexing agent for proton acceptors［J］. Journal of the American Chemical Society, 1988, 110(17): 5896-5897.

[2] [2] CUSTELCEAN R. Crystal engineering with urea and thiourea hydrogen-bonding groups［J］. Chemical Communications, 2008(3): 295-307.

[3] [3] ETTER M C, URBANCZYK-LIPKOWSKA Z, ZIA-EBRAHIMI M, et al. Hydrogen bond-directed cocrystallization and molecular recognition properties of diarylureas［J］. Journal of the American Chemical Society, 1990, 112(23): 8415-8426.

[4] [4] JAGTAP A D, KONDEKAR N B, SADANI A A, et al. Ureas: applications in drug design［J］. Current Medicinal Chemistry, 2017, 24(6): 622-651.

[5] [5] GALLOU I. Unsymmetrical ureas. synthetic methodologies and application in drug design［J］. Organic Preparations and Procedures International, 2007, 39(4): 355-383.

[6] [6] KATSILAMBROS N, DIAKOUMOPOULOU E, IOANNIDIS I, et al. Diabetes in clinical practice［M］. Chichester, UK: John Wiley & Sons, Ltd, 2006.

[7] [7] LODN M. Urea-containing moisturizers influence barrier properties of normal skin［J］. Archives of Dermatological Research, 1996, 288(2): 103-107.

[8] [8] REGAN J, BREITFELDER S, CIRILLO P, et al. Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate［J］. Journal of Medicinal Chemistry, 2002, 45(14): 2994-3008.

[9] [9] WANG H, HUANG B, WANG W, et al. High urea induces depression and LTP impairment through mTOR signalling suppression caused by carbamylation［J］. EBioMedicine, 2019, 48: 478-490.

[10] [10] GARUTI L, ROBERTI M, BOTTEGONI G, et al. Diaryl urea: a privileged structure in anticancer agents［J］. Current Medicinal Chemistry, 2016, 23(15): 1528-1548.

[11] [11] KANDEKAR S, PREET R, KASHYAP M, et al. Structural elaboration of a natural product: identification of 3, 3'-diindolylmethane aminophosphonate and urea derivatives as potent anticancer agents［J］. Chem Med Chem, 2013, 8(11): 1873-1884.

[12] [12] SONG D Q, DU N N, WANG Y M, et al. Synthesis and activity evaluation of phenylurea derivatives as potent antitumor agents［J］. Bioorganic & Medicinal Chemistry, 2009, 17(11): 3873-3878.

[13] [13] LI H Q, LV P C, YAN T, et al. Urea derivatives as anticancer agents［J］. Anti-Cancer Agents in Medicinal Chemistry, 2009, 9(4): 471-480.

[14] [14] BORELLI C, BIELFELDT S, BORELLI S, et al. Cream or foam in pedal skin care: towards the ideal vehicle for urea used against dry skin［J］. International Journal of Cosmetic Science, 2011, 33(1): 37-43.

[15] [15] CIVALLERI B, ZICOVICH-WILSON C M, VALENZANO L, et al. B3LYP augmented with an empirical dispersion term (B3LYP-D*) as applied to molecular crystals［J］. Cryst Eng Comm, 2008, 10(4): 405-410.

[16] [16] TIRADO-RIVES J, JORGENSEN W L. Performance of B3LYP density functional methods for a large set of organic molecules［J］. Journal of Chemical Theory and Computation, 2008, 4(2): 297-306.

[17] [17] Sheldrick G M. SHELXL-2014/7: program for the solution of crystal structures［J］.Gttingen: University of Gttingen, 2014.

[18] [18] Sheldrick G M. SHELXS-2014/7: program for the refinement of crystal structures［J］.Gttingen: University of Gttingen, 2014.

[20] [20] Deppmeier B J, Driessen A J, Hehre T S, et al. Spartan ‘08, V1.0.0［CP］. Irvine CA: Wavefunction Inc, 2009.